Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Server Slowdowns and GRACE Update
Author
Denise Brock
Image

You may have noticed some frustrating server issues with GRACE these past few days.  Our true apologies – we are working diligently with our provider to solve these issues.  We ask you for patience, and we will be hopefully trouble free as soon as possible.  


Recent cancerGRACE.org issues have made me feel that it is a great time to give people a sneak peek at what we are working on behind the scenes.  GRACE is past due for an upgrade – and we have decided to give the site a shiny new coat of paint. Soon you will be seeing a new site when you log in to GRACE – and while change is always a little tough – we think you will like what you see.  

Our great development team at FUSEIQ based in Seattle has shown that they have a wonderful understanding of what we do and what we are trying to do.  They have worked with many nonprofits and have an excellent team who have been patient and understanding with our requests.  Their knowledge has been guiding us to develop a site that is intuitive, easy to navigate and much easier to find the important information that is so integral to the heart of GRACE.  We also will be implementing a new structure for our FORUMS – yes – many of the abilities that we have been promising since the last upgrade will finally be available.  Welcome back, personal messaging! 

Another very very exciting part of this rebuild is that we are giving you – our members – more control over what information you want to see.  When you have an account on GRACE, you will be able to personalize your dashboard so you see the information you want to see!  As GRACE grows, we hope to provide more and more information about different types of cancers.  We also know that not everyone – though it is all incredibly interesting and educational – wants to wade through new information on types of cancers that are not necessarily pertinent to them.  The new GRACE site will allow you to determine what feeds you get to see daily on your own dashboard.  You also can always default to the main page to see what is new, available site wide.  Here is a sneak peek! 

 

 Please feel free to offer comments and raise questions in our Discussion Forums.


Do you want to help us reach our goal?  

AS you know, GRACE is a nonprofit run solely on grants and donations from our users.   Funding is tight – and we hope to be able to launch the new site not only as a pretty new thing, but with our content and data migrated over successfully.  Operational tasks are always tough to find funding for!   

If you would like to help us reach our goal, you can donate HERE.  

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Blood Cancers OncTalk
Article
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk!  Register Now!
Image
PEA 2024-25 final
Article
GRACE is pleased to announce the acceptance of five rising stars into the 6th year of the GRACE Patient Education Ambassadors Program for the 2024-25 Program Year! 
Image
2024 patient education ambassadors program
Article
Applications are now open to oncology fellows and finishing fellows Program Information Form and Application

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on